Back to Results
First PageMeta Content
Organic chemistry / Tipranavir / Boehringer Ingelheim / Propylene glycol / Excipient / Ritonavir / Fluoride / Electronic cigarette / Antiretroviral drug / Protease inhibitors / Chemistry / Pharmacology


sbd_smd_2006_aptivus_098651_e.doc
Add to Reading List

Document Date: 2013-07-12 14:26:14


Open Document

File Size: 474,92 KB

Share Result on Facebook

Company

FOREWORD Health Canada / Boehringer Ingelheim (Canada) Ltd. / Health Canada Boehringer Ingelheim (Canada) Ltd. / /

Country

Canada / /

Currency

pence / /

Event

FDA Phase / /

IndustryTerm

bulk fill solution / Black printing ink / drug product / treatment of HIV / therapies for HIV / manufacturing technology / self-emulsifying drug delivery systems / particular product / manufacturing / degradation products / oil-in-water emulsions / p55 gag cleavage site / food / manufacturing process / /

MedicalCondition

HIV / hypersensitivity / hepatic insufficiency / /

MedicalTreatment

antiretroviral treatment / drug delivery systems / /

Organization

Health Products and Food Branch / /

Position

Representative / /

Product

APTIVUS / Dosage form Capsule / sorbitol / EL / mannitol / Self-Emulsifying Drug / CYP3A / SBD / /

PublishedMedium

the Health Canada review / /

Technology

Pharmacokinetics / drug delivery / Drug Delivery System / Pharmacodynamics / /

SocialTag